Last update 08 May 2025

TER-101

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target-
Action-
Mechanism-
Therapeutic Areas
Immune System DiseasesCongenital DisordersSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Dermatitis, AtopicMild Atopic DermatitisModerate Atopic Dermatitis
Originator Organization
Volvat Medisinske Senter ASVolvat Medisinske Senter AS
Active Organization-
Inactive Organization
Teres Bio, Inc.Volvat Medisinske Senter ASVolvat Medisinske Senter AS
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with TER-101
NCT04753034
/ CompletedPhase 2
A Multicenter, Randomized, Double-blind, Vehicle-Controlled, Phase 2 Study of TER-101 Topical Ointment to Assess Efficacy and Safety in Subjects With Mild to Moderate Atopic
100 Clinical Results associated with TER-101
Login to view more data
100 Translational Medicine associated with TER-101
Login to view more data
100 Patents (Medical) associated with TER-101
Login to view more data
100 Deals associated with TER-101
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Mild Atopic DermatitisPhase 2
United States
Teres Bio, Inc.
18 Jan 2021
Moderate Atopic DermatitisPhase 2
United States
Teres Bio, Inc.
18 Jan 2021
Dermatitis, AtopicPhase 2
United States
Volvat Medisinske Senter ASVolvat Medisinske Senter AS
31 Dec 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT04753034 (CTgov)
Phase 2
Moderate Atopic Dermatitis | Mild Atopic Dermatitis
63
(TER-101)
yhtmkyxtkv(lobzwhlwfo) = djnuvgspig myqvkwcrpe (rfdosejkwy, ovimbnjglm - eqzxhpssdh)
View more
-
19 Jul 2022
Vehicle
(Vehicle)
yhtmkyxtkv(lobzwhlwfo) = xsgjelvxkd myqvkwcrpe (rfdosejkwy, bimrylzlhk - ilwdqtbsvl)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free